European Global Times
SEE OTHER BRANDS

The most trusted news from Europe

European Global Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.

Press releases published on June 16, 2025

Discovery Announces Management Appointments

Discovery Announces Management Appointments

TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced the hiring of Amy Hu as Senior Vice President, Legal and Sustainability and Darin Smith as Senior Vice President, …

Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology

Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology Research builds on Emory’s research on influenza vaccines self-administered via …

Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 85th Scientific Sessions

Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 85th Scientific Sessions

– Hengrui to present six abstracts highlighting clinical progress of GLP-1/GIP dual receptor agonist HRS9531 (KAI-9531) and GLP-1 receptor agonist HRS-7535 (KAI-7535) in type 2 diabetes and obesity – JIANGSU, China and BOSTON, June 16, 2025 (GLOBE NEWSWIRE …

Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio

Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio

Proposed acquisition expected to accelerate mid- to long-term revenue and cash flow growth and further diversify revenue base. Strengthens Supernus’ leading presence in neuropsychiatric conditions with an innovative commercial product, ZURZUVAE® ( …

Nokia announces changes to Group Leadership Team

Nokia announces changes to Group Leadership Team

Nokia Corporation Stock Exchange Release 16 June 2025 at 14:00 EEST Nokia announces changes to Group Leadership Team Federico Guillén to retire from Nokia on 31 December 2025. He will step down as President of the Network Infrastructure (NI) business group …

Nokia ilmoittaa muutoksista johtoryhmän kokoonpanossa

Nokia ilmoittaa muutoksista johtoryhmän kokoonpanossa

Nokia Oyj Pörssitiedote 16.6.2025 klo 14:00 EEST Nokia ilmoittaa muutoksista johtoryhmän kokoonpanossa Federico Guillén jää eläkkeelle tehtävistään Nokiassa 31.12.2025. Hän jättää tehtävänsä Nokian Verkkoinfrastruktuuri-liiketoimintaryhmän johtajana ja …

Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway

Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway

- New data show clinical safety and early efficacy of SANA, a first-in-class compound that targets creatine-dependent thermogenesis MONTEVIDEO, Uruguay, June 16, 2025 (GLOBE NEWSWIRE) -- Eolo Pharma, a clinical-stage biotechnology company developing …

BioCryst Presents New Data on the Long-term Efficacy and Safety of ORLADEYO® (berotralstat) Across all Ages at EAACI

BioCryst Presents New Data on the Long-term Efficacy and Safety of ORLADEYO® (berotralstat) Across all Ages at EAACI

—Data across pediatric, adolescent, and adult populations demonstrate sustained reductions in HAE attacks and consistent safety profile— —Patients report improved quality of life and daily functioning with ORLADEYO— RESEARCH TRIANGLE PARK, N.C., June 16, …

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025

BEDFORD, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation at Clinical Trials at the Summit …

Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics

Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics

Three Phase 1 studies support once-daily inhaled administration of mosliciguat with no evidence of serious systemic side effects Results informed the ongoing Phase 2 PHocus study of mosliciguat for the treatment of pulmonary hypertension associated with …

Mirasol Signs MOU for the Sale of the Virginia Silver Project and Landholdings in Argentina for US$8 Million Plus 2% NSR Royalty

Mirasol Signs MOU for the Sale of the Virginia Silver Project and Landholdings in Argentina for US$8 Million Plus 2% NSR Royalty

Ampere Metals to acquire Virginia Project for a total consideration of US$ 8.0 million: US$5 million for the sale of the mineral rights and US$3 million for the sale of the landholdings over 5 years of scheduled payments Mirasol will retain a 2% NSR …

Pharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat Bradykinin-Mediated Angioedema Attacks at the EAACI Congress

Pharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat Bradykinin-Mediated Angioedema Attacks at the EAACI Congress

ZUG, Switzerland, June 16, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases …

VEON Announces USD 35 Million Share Buyback

VEON Announces USD 35 Million Share Buyback

Announcement marks the third phase of USD 100 million share buyback program  Dubai, June 16, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), announces that it will shortly commence the third phase of its previously …

Inflection Resources to Acquire Portfolio of Australian Copper-Gold Projects from Newmont Corporation

Inflection Resources to Acquire Portfolio of Australian Copper-Gold Projects from Newmont Corporation

VANCOUVER, British Columbia, June 16, 2025 (GLOBE NEWSWIRE) -- Inflection Resources Ltd. (CSE: AUCU / OTCQB: AUCUF / FSE: 5VJ) (the "Company" or "Inflection") is pleased to announce it has entered into definitive agreement dated June 13, 2025 to acquire an …

Second Drill Hole at Potro SE Extends Polymetallic Mineralization at Mirasol’s Flagship Sobek Gold-Silver-Copper Project in the Vicuña District, Chile

Second Drill Hole at Potro SE Extends Polymetallic Mineralization at Mirasol’s Flagship Sobek Gold-Silver-Copper Project in the Vicuña District, Chile

Second drill hole testing the Potro SE target intersected the continuation of a polymetallic hydrothermal breccia system: 0.90m at 15.02 g/t gold Eq and 17.65m at 0.22 g/t gold Eq with high silver, lead, zinc and indications of copper The mineralized …

La RSE, un levier de développement pour Provectio

La RSE, un levier de développement pour Provectio

L’Entreprise de Services Numériques Provectio mise sur le développement durable et responsable en présentant les résultats de sa démarche de réemploi et de gestion de fin de vie des produits, lancée en 2023. Cette initiative s’inscrit dans l’évolution de …

AVEROA receives European marketing authorization for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)

AVEROA receives European marketing authorization for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)

XOANACYL is an oral therapy designed to address critical challenges in CKD, including Iron deficiency and hyperphosphatemia Averoa submitted XOANACYL for UK approval via MHRA’s International Recognition Procedure AVEROA actively seeking strategic partners …

ISS further renews and expands public healthcare contract in Southeast Asia

ISS further renews and expands public healthcare contract in Southeast Asia

Copenhagen , June 16, 2025 (GLOBE NEWSWIRE) -- Under the contract, which commences in July 2025, ISS will deliver services across a range of public healthcare institutions. The contract forms part of a larger tender from which ISS has already secured new …

ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope

ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope

Garching / Munich, Germany, and Grenoble, France, June 16, 2025 – ITM Isotope Technologies Munich SE (ITM) and the Institut Laue-Langevin (ILL), today announced an extension of their collaboration for medical radioisotope production, originally established …

ETHRANSaction Launches 2025 Cloud Mining Event, Ushering in a New Phase of Passive Crypto Income

ETHRANSaction Launches 2025 Cloud Mining Event, Ushering in a New Phase of Passive Crypto Income

York, England, UK, June 16, 2025 (GLOBE NEWSWIRE) -- New mining plans, simplified onboarding, and global expansion mark a major step forward in ETHRANSaction’s mission to democratize crypto earnings In a significant move for crypto enthusiasts and passive …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service